- Tytuł:
- Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases December 2022 22(12):1703-1715
Czasopismo naukowe